{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:23:08Z","timestamp":1791926588989,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100010659","name":"Erasmus MC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.ejca.2018.09.036","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T13:01:59Z","timestamp":1542027719000},"page":"79-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Opioid responsiveness of nociceptive versus mixed pain in clinical cancer patients"],"prefix":"10.1016","volume":"105","author":[{"given":"Malik","family":"Bechakra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floor","family":"Moerdijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9187-244X","authenticated-orcid":false,"given":"Joost","family":"van Rosmalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit C.P.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carin C.D.","family":"van der Rijt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.E.","family":"Sillevis Smitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8340-2755","authenticated-orcid":false,"given":"Joost L.M.","family":"Jongen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ejca.2018.09.036_bib1","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/annonc\/mdm056","article-title":"Prevalence of pain in patients with cancer: a systematic review of the past 40 years","volume":"18","author":"van den Beuken-van Everdingen","year":"2007","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2018.09.036_bib2","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/annonc\/mdq449","article-title":"First evidence of oncologic neuropathic pain prevalence after screening 8615 cancer patients. Results of the on study","volume":"22","author":"Garcia de Paredes","year":"2011","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2018.09.036_bib3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.pain.2011.10.028","article-title":"Prevalence and aetiology of neuropathic pain in cancer patients: a systematic review","volume":"153","author":"Bennett","year":"2012","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.ejca.2018.09.036_bib4","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jpainsymman.2012.10.230","article-title":"The evidence for pharmacologic treatment of neuropathic cancer pain: beneficial and adverse effects","volume":"46","author":"Jongen","year":"2013","journal-title":"J Pain Symptom Manag"},{"issue":"8","key":"10.1016\/j.ejca.2018.09.036_bib5","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.ejca.2009.01.007","article-title":"A systematic review on barriers hindering adequate cancer pain management and interventions to reduce them: a critical appraisal","volume":"45","author":"Oldenmenger","year":"2009","journal-title":"Eur J Canc"},{"issue":"3","key":"10.1016\/j.ejca.2018.09.036_bib6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.pain.2006.02.002","article-title":"Can pain can be more or less neuropathic? Comparison of symptom assessment tools with ratings of certainty by clinicians","volume":"122","author":"Bennett","year":"2006","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.ejca.2018.09.036_bib7","first-page":"104","article-title":"The differential effects of morphine and the alpha 2-adrenoceptor agonists clonidine and dexmedetomidine on the prevention and treatment of experimental neuropathic pain","volume":"77","author":"Puke","year":"1993","journal-title":"Anesth Analg"},{"issue":"3","key":"10.1016\/j.ejca.2018.09.036_bib8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0304-3959(02)00102-1","article-title":"Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs. inflammatory pain","volume":"99","author":"Luger","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.ejca.2018.09.036_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0304-3959(88)90198-4","article-title":"Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain","volume":"33","author":"Arner","year":"1988","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.ejca.2018.09.036_bib10","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1212\/WNL.44.5.857","article-title":"Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms: a combined analysis of controlled, single-dose studies","volume":"44","author":"Cherny","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.ejca.2018.09.036_bib11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0304-3959(90)90025-9","article-title":"The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions","volume":"43","author":"Portenoy","year":"1990","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.ejca.2018.09.036_bib12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0304-3959(98)00256-5","article-title":"Are opioids effective in relieving neuropathic pain?","volume":"80","author":"Dellemijn","year":"1999","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.ejca.2018.09.036_bib13","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jpain.2008.12.002","article-title":"Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patients","volume":"10","author":"Mercadante","year":"2009","journal-title":"J Pain"},{"issue":"3","key":"10.1016\/j.ejca.2018.09.036_bib14","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/bmjspcare-2011-000087","article-title":"Effectiveness of a multidisciplinary consultation team for cancer pain and palliative care in a large university hospital in the Netherlands","volume":"1","author":"Jongen","year":"2011","journal-title":"BMJ Support Palliat Care"},{"issue":"18","key":"10.1016\/j.ejca.2018.09.036_bib15","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/01.wnl.0000282763.29778.59","article-title":"Neuropathic pain: redefinition and a grading system for clinical and research purposes","volume":"70","author":"Treede","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.ejca.2018.09.036_bib16","unstructured":"Landelijke richtlijn pijn bij kanker (1.0). Consensus Guideline. Utrecht: Integraal Kankercentrum Nederland; 2008 02-06-2008."},{"issue":"2","key":"10.1016\/j.ejca.2018.09.036_bib17","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0885-3924(01)00294-9","article-title":"Equianalgesic dose ratios for opioids. A critical review and proposals for long-term dosing","volume":"22","author":"Pereira","year":"2001","journal-title":"J Pain Symptom Manag"},{"issue":"Suppl 1","key":"10.1016\/j.ejca.2018.09.036_bib18","doi-asserted-by":"crossref","first-page":"s25","DOI":"10.1191\/0269216306pm1125oa","article-title":"Transdermal buprenorphine in cancer pain and palliative care","volume":"20","author":"Sittl","year":"2006","journal-title":"Palliat Med"},{"key":"10.1016\/j.ejca.2018.09.036_bib19","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jpba.2017.11.035","article-title":"Bioanalytical methods for the quantification of hydromorphone, fentanyl, norfentanyl, morphine, morphine-3ss-glucuronide and morphine-6ss-glucuronide in human plasma","volume":"149","author":"de Bruijn","year":"2018","journal-title":"J Pharmaceut Biomed Anal"},{"issue":"12","key":"10.1016\/j.ejca.2018.09.036_bib20","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.2217\/pgs-2017-0060","article-title":"Advanced cancer pain: the search for genetic factors correlated with interindividual variability in opioid requirement","volume":"18","author":"Matic","year":"2017","journal-title":"Pharmacogenomics"},{"issue":"4","key":"10.1016\/j.ejca.2018.09.036_bib21","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0936-6555(02)00400-4","article-title":"A ppopulation-based study of malignant spinal cord compression in ontario","volume":"15","author":"Loblaw","year":"2003","journal-title":"Clin Oncol"},{"issue":"9486","key":"10.1016\/j.ejca.2018.09.036_bib22","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0140-6736(05)66954-1","article-title":"Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: a randomised trial","volume":"366","author":"Patchell","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2018.09.036_bib23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12904-015-0045-8","article-title":"Incidence of pain flare following palliative radiotherapy for symptomatic bone metastases: multicenter prospective observational study","volume":"14","author":"Gomez-Iturriaga","year":"2015","journal-title":"BMC Palliat Care"},{"key":"10.1016\/j.ejca.2018.09.036_bib24","first-page":"CD010270","article-title":"Transdermal fentanyl for cancer pain","volume":"10","author":"Hadley","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejca.2018.09.036_bib25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejca.2016.06.025","article-title":"Methadone is superior to fentanyl in treating neuropathic pain in patients with head-and-neck cancer","volume":"65","author":"Haumann","year":"2016","journal-title":"Eur J Canc"},{"issue":"1","key":"10.1016\/j.ejca.2018.09.036_bib26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1200\/JCO.2004.03.172","article-title":"Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study","volume":"22","author":"Bruera","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2018.09.036_bib27","first-page":"CD003351","article-title":"Ketamine as an adjuvant to opioids for cancer pain","volume":"11","author":"Bell","year":"2012","journal-title":"Cochrane Database Syst Rev"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804918314060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804918314060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T20:59:10Z","timestamp":1662411550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804918314060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":27,"alternative-id":["S0959804918314060"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2018.09.036","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opioid responsiveness of nociceptive versus mixed pain in clinical cancer patients","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2018.09.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}